Literature DB >> 11388745

Immunophenotypic characteristics of PB-mobilised CD34+ hematopoietic progenitor cells.

P Menéndez1, M C del Cañizo, A Orfao.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11388745

Source DB:  PubMed          Journal:  J Biol Regul Homeost Agents        ISSN： 0393-974X            Impact factor:   1.711


× No keyword cloud information.
  6 in total

1.  Nodal/Activin signaling predicts human pluripotent stem cell lines prone to differentiate toward the hematopoietic lineage.

Authors:  Veronica Ramos-Mejia; Gustavo J Melen; Laura Sanchez; Ivan Gutierrez-Aranda; Gertrudis Ligero; Jose L Cortes; Pedro J Real; Clara Bueno; Pablo Menendez
Journal:  Mol Ther       Date:  2010-08-24       Impact factor: 11.454

2.  Cord blood-derived CD34+ hematopoietic cells with low mitochondrial mass are enriched in hematopoietic repopulating stem cell function.

Authors:  Damia Romero-Moya; Clara Bueno; Rosa Montes; Oscar Navarro-Montero; Francisco J Iborra; Luis Carlos López; Miguel Martin; Pablo Menendez
Journal:  Haematologica       Date:  2013-01-24       Impact factor: 9.941

3.  CD34+ cell subpopulations detected by 8-color flow cytometry in bone marrow and in peripheral blood stem cell collections: application for MRD detection in leukemia patients.

Authors:  Elisabet Björklund; Astrid Gruber; Joanna Mazur; Anna Mårtensson; Mona Hansson; Anna Porwit
Journal:  Int J Hematol       Date:  2009-08-29       Impact factor: 2.490

4.  Residual expression of the reprogramming factors prevents differentiation of iPSC generated from human fibroblasts and cord blood CD34+ progenitors.

Authors:  Verónica Ramos-Mejía; Rosa Montes; Clara Bueno; Verónica Ayllón; Pedro J Real; René Rodríguez; Pablo Menendez
Journal:  PLoS One       Date:  2012-04-24       Impact factor: 3.240

5.  Next generation flow for minimally-invasive blood characterization of MGUS and multiple myeloma at diagnosis based on circulating tumor plasma cells (CTPC).

Authors:  L Sanoja-Flores; J Flores-Montero; J J Garcés; B Paiva; N Puig; A García-Mateo; O García-Sánchez; A Corral-Mateos; L Burgos; E Blanco; J Hernández-Martín; R Pontes; M Díez-Campelo; P Millacoy; P Rodríguez-Otero; F Prosper; J Merino; M B Vidriales; R García-Sanz; A Romero; L Palomera; R Ríos-Tamayo; M Pérez-Andrés; J F Blanco; M González; J J M van Dongen; B Durie; M V Mateos; J San-Miguel; A Orfao
Journal:  Blood Cancer J       Date:  2018-11-19       Impact factor: 11.037

6.  H3K79me2/3 controls enhancer-promoter interactions and activation of the pan-cancer stem cell marker PROM1/CD133 in MLL-AF4 leukemia cells.

Authors:  Laura Godfrey; Nicholas T Crump; Sorcha O'Byrne; I-Jun Lau; Siobhan Rice; Joe R Harman; Thomas Jackson; Natalina Elliott; Gemma Buck; Christopher Connor; Ross Thorne; David J H F Knapp; Olaf Heidenreich; Paresh Vyas; Pablo Menendez; Sarah Inglott; Philip Ancliff; Huimin Geng; Irene Roberts; Anindita Roy; Thomas A Milne
Journal:  Leukemia       Date:  2020-04-02       Impact factor: 12.883
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.